In a plenary session at the annual American Academy of Neurology meeting, Paul Edison, MD, PhD, of Imperial College London in ...

Lixisenatide is an older drug in the same class as Novo Nordisk’s big-selling Ozempic/Wegovy (semaglutide), used to treat type 2 diabetes and obesity, as well as to reduce the risk of ...

This belief comes after a mid-stage clinical study suggested that the diabetes medication lixisenatide ... drug is part of a popular group of obesity treatments known as GLP-1 agonists, a class ...